Ticker Details
Charles River Laboratories International, Inc. Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.
IPO Date:	June 23, 2000
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$8.31B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.40 | 1.21%
Avg Daily Range (30 D):	$5.00 | 2.67%
Avg Daily Range (90 D):	$3.35 | 1.80%

Institutional Daily Volume
Avg Daily Volume:	.53M
Avg Daily Volume (30 D):	.86M
Avg Daily Volume (90 D):	.75M

Trade Size
Avg Trade Size (Sh.):	87
Avg Trade Size (Sh.) (30 D):	40
Avg Trade Size (Sh.) (90 D):	39

Institutional Trades
Total Institutional Trades:	13,493
Avg Institutional Trade:	$4.29M
Avg Institutional Trade (30 D):	$10.34M
Avg Institutional Trade (90 D):	$12.17M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$8.76M
Avg Closing Trade (30 D):	$24.18M
Avg Closing Trade (90 D):	$25.62M
Avg Closing Volume:	56.32K

News

Feb 3, 2026 @ 6:00 PM [Latest] Global Adeno Associated Virus Vector Manu... Source: Custom Market Insights

Nov 28, 2025 @ 3:00 PM Lead Optimization Services in Drug Discovery Marke... Source: Towards Healthcare

Nov 28, 2025 @ 2:00 PM Innovative Drug CRO Market to Soar USD 96.06 Billi... Source: Towards Healthcare

Nov 5, 2025 @ 6:38 PM Charles River Beat Expectations But Why Is The Sto... Source: Vandana Singh

Oct 30, 2025 @ 8:59 AM Cell-based Assays Market Size to Reach USD 35.34 B... Source: Sns Insider

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-2.91	$-5.57	$-2.91
Diluted EPS	$-2.91	$-5.56	$-2.91
Revenue	$4.02B	$994.23M	$4.02B
Gross Profit
Net Income / Loss	$-142.16M	$-276.29M	$-142.16M
Operating Income / Loss	$25.16M	$-283.44M	$25.16M
Cost of Revenue
Net Cash Flow	$10.43M	$6.78M	$10.43M
PE Ratio